Trophoblastic disease

Trophoblastic disease encompasses a group of trophoblast abnormalities always associated with pregnancy. The urgency of studying the problemof the diagnosis and treatment of this pathology is clear because of the young age of patients, the high efficiency of treatment for malignant forms of the disease even in distant metastases and the possibility of their complete cure in 98 % of the patients with preserved reproductive function. The keystone of success is the correct and timely diagnosis of the disease and current highly effective treatment in the specialized clinic having all diagnostic facilities and successful experience in treating these patients. Clinicians» knowledge of the problem allows the avoidance of frequent errors both in the diagnosis and choice of treatment policy for patients with malignant trophoblastic tumors that may be fatal for some patients. The paper illustrates theoretical aspects with the results of treatment in patients at the N. N. Blokhin Russian Cancer Research Center that is an expert in the diagnosis and treatment of trophoblastic tumors in Russia. The paper deals with the diagnosis, treatment, and monitoring of trophoblastic disease.

1. Bagshawe K.D. Trophoblastic tumors: diagnostic methods, epidemiology, clinical features and management. Gynecol Оncol 1995;1027–43.

2. Berkowitz R.S., Goldstein D.P. Chorionic tumours. N Engl J Med 1996;335(23):1740–8.

3. Berkowitz R.S., Goldstein D.P. Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol 1998;10(1):61–4.

4. Ngan H.Y. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer 2004;14(2):202–5.

5. Shimizu T., Yaegashi N. Gestational trophoblastic tumors and recent clinical information. Gan To Kagaku Ryoho 2002;29(8):1363–70.

6. Sugarman S.M., Kavanagh J.J. Gestational trophoblastic tumors. Medical Oncology: a comprehensive review 1993;245–54.

7. Wang Y.X., Zhang X., Guan Y.L. et al. Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi 2005;40(2): 87–90.

8. Wolf N.G., Lage J.M. Genetic analysis of gestational trophoblastic disease: a review. Semin Oncol 1995;22(2): 113–8.

9. Bagshawe K.D. Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29(11):813–20.

10. Alifrangis C., Agarwal R., Short D. et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction lowdose etoposide-cisplatin and genetic analysis. J Clin Oncol 2013;31(2):280–6.

11. Bolis G., Bonazzi C., Landoni F. et al. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 1988;31(3):439–44.

12. Bower M., Newlands E.S., Holden L. et al. EMA/CO for high-risk trophoblastic tumor: results from a cohort of 272 patients. J Clin Oncol 1997;15(7):2636–43.

13. DeBaz B.P., Lewis T.J. Imaging of gestational trophoblastic disease. Semin Oncol 1995;22(2):130–41.

14. Fisher P.M., Hancock B.W. Gestational trophoblastic diseases and their treatment. J Oncol Med 1997;23(1):1–16.

15. Freedman R.S., Tortolero-Luna G., Pandey D.K. et al. Gestational trophoblastic disease. Obstet Gynecol Clin North Am 1996;23(2):545–71.

16. Lurain J.R. Gestational trophoblastic tumors. Semin Surg Oncol 1990;6(6):347–53.

17. Fu J., Fang F., Xie L. et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;10:CD007289.

18. Baergen R.N., Rutgers J.L., Young R.H. et al. Placental site trophoblastic tumor: а study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006;100(3):511–20.

19. Behnamfar F., Mousavi A., Rezapourian P., Zamani A.E. Placental site trophoblastic tumor, report of a case with unusual presentation. Еur J Nucl Med Mol Imaging 2013;40(4):505–13.

20. Deng S., Yang X.Y. Diagnosis and therapeutics of placental site trophoblastic tumor. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002;24(4):418–21.

21. Hyman D.M., Bakios L., Gualtiere G. et al. Placental site trophoblastic tumor: аnalysis of presentation, treatment, and outcome. Gynecol Oncol 2013;129(1):58–62.

22. Kim S.J. Placental site trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 2003;17(6):969–84.

23. Moutte A., Doret M., Hajri T. et al. Placental site and epithelioid trophoblastic tumours: diagnostic pitfalls. Gynecol Oncol 2013;128(3):568–72.

24. Rhoton V.A., Wagner J.M., Rutgers J.L. et al. Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers. Hum Pathol 1998;29(3):280–8.

25. Shen X., Xiang Y., Guo L. et al. Fertilitypreserving treatment in young patients with placental site trophoblastic tumors. Int J Gynecol Cancer 2012;22(5):869–74.

26. Allison K.H., Love J.E., Garcia R.L. Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med 2006;130(12):1875–7.

27. Kuo K.T., Chen M.J., Lin M.C. Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature. Am J Surg Pathol 2004;28(3):405–9.

28. Ohira S., Yamazaki T., Hatano H. еt al. Epithelioid trophoblastic tumor metastatic to the vagina: an immunohistochemical and ultrastructural study. Int J Gynecol Pathol 2000;19(4):381–6.

29. Scott E.M., Smith A.L., Desouki M.M., Olawaiye A.B. Epithelioid trophoblastic tumor: a case report and review of the literature. Case Rep Obstet Gynecol 2012;2012:862472.

30. Sung W.J., Shin H.C., Kim M.K., Kim M.J. Epithelioid trophoblastic tumor: clinicopathologic and immunohistochemical analysis of three cases.Korean J Pathol 2013;47(1):67–73.

31. Vencken P.M., Ewing P.C., Zweemer R.P. Epithelioid trophoblastic tumour: a case report and review of the literature. J Clin Pathol 2006;59(12):1307–8.

32. Tsukamoto N., Iwasaka T., Kashimura Y. et al. Gestational trophoblastic disease in women aged 50 or more. Gynecol Oncol 1985;20(1):53–61.

33. Hasanzadeh M., Sharifi N., Esmaieli H. et al. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiformmoles and its diagnostic value in the progression to gestational trophoblastic neoplasia. J Obstet Gynaecol Res 2013;39(2):572–7.

34. Betel C., Atri M., Arenson A.M., Khalifa M. et al. Sonographic diagnosis of gestational trophoblastic disease and comparison with retained products of conception. Ultrasound Med 2006;25(8):985–93.

35. Bidzinski M., Lemieszczuk B., Drabik M. The assessement of value of transvaginal ultrasound for monitoring of gestational trophoblastic diseases treatment. Eur J Gynaecol Oncol 1997;18(6):541–3.

36. Kohorn E.I., McCarthy S.M., Taylor K.J. Nonmetastatic gestational trophoblastic neoplasia: role of ultrasonography and magnetic resonance imaging. J Reprod Med Obstet Gynecol 1998;43(1):14–20.

37. Nikolic B., Lukic R. Choriocarcinoma – post disease ultrasonographic findings. Int J Gynecol Cancer 2004;14(4):677–9.

38. Chang T.C., Yen T.C., Li Y.T. et al. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study. Eur J Nucl Med Mol Imaging 2006;33(2):156–63.

39. Dhillon T., Palmieri C., Sebire N.J. et al. Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 2006;51(11):879–87.

40. Lai C.H., Yen T.C., Chang T.C. Positron emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 2007;19(1):37–41.

41. Mapelli P., Mangili G., Picchio M. et al. Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia. Eur J Nucl Med Mol Imaging 2013;40(4): 505–13.

42. Sironi S., Picchio M., Mangili G. et al. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. Gynecol Oncol 2003;91(1):226–30.

43. McNeish I.A., Stricland S., Holden L. et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment withlow-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20(7):1838–44.

44. Ghaemmaghami F., Modares M., Arab M. et al. EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV). Int J Gynecol Cancer 2004;14(2):360–5.

45. Lurain J.R., Nejad B., John I. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97(2):618–23.

46. Lybol C., Thomas C.M., Blanken E.A. et al. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Eur J Cancer 2013;49(4):860–7.

47. Lybol C., Westerdijk K., Sweep F.C. et al. Human chorionic gonadotropin (hCG) regression normograms for patients with highrisk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy. Ann Oncol 2012;23(11):2903–6.

48. Alazzam M., Tidy J., Osborne R. et al. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012;12:CD008891.

49. Meshcheryakova L.A., Kozachenko V.P., Meshcheryakov A.A. Chemotherapy in resistant gestational trophoblastic tumor (GTT). Int J Gynecol Cancer 2003;13(1):102.

50. Newlands E.S., Bower M., Holden L. et al. Management of resistant gestational trophoblastic tumors. J Reprod Med Obstet Gynecol 1998;43(2):111–8.

51. Alifrangis C., Wilkinson M.J., Stefanou D.C. et al. Role of thoracotomy and metastatectomy in gestational trophoblastic neoplasia: a single center experience. J Reprod Med 2012;57(7–8):350–8.

52. Lurain J.R., Singh D.K., Schink J.C., John I. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006;51(10):773–6.

53. Pires L.V., Uberti E.M., Fajardo Mdo C. et al. Role of hysterectomy in the management of patients with gestational trophoblastic neoplasia: importance of receiving treatment in reference centers. J Reprod Med 2012; 57(7–8):359–68.

54. Sablinska B., Kietlinska Z., Zielinski J. Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD). Eur J Gynaecol Oncol 1993; 14 Suppl:146–51.

55. Sergent F., Verspyck E., Lemoine J.P., Marpeau L. Place of surgery in the management of gestational trophoblastic tumors. Gynecol Obstet Fertil 2006; 34(7–8):670.

56. Zhang Y., Xiang Y., Ren T. et al. Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor. Zhonghua Fu Chan Ke Za Zhi 2005;40(2):83–6.

57. Cagayan M.S., Lu-Lasala L.R. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: a 12-year review at the Philippine General Hospital. J Reprod Med 2006;51(10):785–92.

58. Evans A.C. Jr., Soper J.T., Clarke-Pearson D.L. et al. Gestational trophoblastic disease metastatic to the entral nervous system. Gynecol Oncol 1995;59(2):226–30.

59. Neubauer N.L., Latif N., Kalakota K. et al. Brain metastasis in gestational trophoblastic neoplasia: an update. J Reprod Med 2012;57(7–8):288–92.

60. Schechter N.R., Mychalczak B., Jones W. et al. Prognosis of patients treated with wholebrain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol 1998;68(2):183–92.

61. Semple P.L., Denny L., Coughlan M. et al. The role neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases. Int J Gynecol Cancer 2004;14(1):157–61.

62. Soper J.T., Spillman M., Sampson J.H. et al. High-risk gestational trophoblastic neoplasia with brain metastases: Individualized multidisciplinary therapy in the management of four patients. Gynecol Oncol 2007;104(3):691–4.

63. Yang J.J., Xiang Y., Yang X.Y. et al. Evaluation of emergency craniotomy for the treatment of patients with intracranial metastases of choriocarcinoma. Zhonghua Fu Chan Ke Za Zhi 2005;40(5):335–8.

64. Bates M., Everard J., Wall L. et al. Is there a relationship between treatment for infertility and gestational trophoblastic disease? Hum Reprod 2004;19(2):365–7.